China MedTech CEO Roundtable Q3

Q1:Q3. Assuming fast expansion of VBP and DRG, how would you see the GTM model will evolve in MedTech in next 3-5 years?

A. Companies will move toward an at-scale direct model across China, and only leverage distributors as logistics providers

B. Companies will move toward direct model in VBP-impacted regions, and only leverage distributors as a logistic provider